Andrew J. Fromkin

IMVT

Andrew J. Fromkin serves as Director at Immunovant, Inc. (IMVT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$43.5K

Total Sells

3 trades

$1.16M

Net Position

Net Seller

$1.12M

Companies Traded

IMVT

Active Period

Aug 2021 – Dec 2025

4 total trades

Most Recent

Sell IMVT

Dec 1, 2025 · $517.2K

Andrew J. Fromkin's Insider Trading at Immunovant, Inc. (IMVT)

Buys

1 · $43.5K

Sells

3 · $1.16M

Total Shares Bought

5,500

Total Shares Sold

42,599

IMVT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 1, 2025	Sell	22,249	$23.25	$517.2K	0
Mar 7, 2025	Sell	8,000	$19.60	$156.8K	0
Dec 5, 2023	Sell	12,350	$39.73	$490.7K	97,067
Aug 11, 2021	Buy	5,500	$7.90	$43.5K	45,700

Related Insiders

Tuyl Christopher Van

officer: Chief Legal Officer

IMVTSell · Mar 20, 2026

Melanie Gloria

officer: Chief Operating Officer

IMVTSell · Feb 27, 2026

Jay S Stout

Chief Technology Officer

IMVTSell · Jan 21, 2026

Douglas J. Hughes

Director

IMVTSell · Dec 1, 2025

Michael Geffner

Chief Medical Officer

IMVTSell · Oct 22, 2025

Peter Salzmann

Chief Executive Officer

IMVTSell · Apr 16, 2025

Eva Renee Barnett

Chief Financial Officer

IMVTSell · Apr 16, 2025

Explore More Insider Trading Data

IMVT Insider Trading Activity

View all insider trades at Immunovant, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity